TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
31 hedge funds and large institutions have $14.6M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
5
Reduced
7
Closed
6
Calls
$63K
Puts
$3K
Net Calls
+$60K
Net Calls Change
+$8K
Top Buyers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$6.84M |
2 |
2
Renaissance Technologies
New York
|
$201K |
3 |
VF
3
Virtu Financial
New York
|
$67K |
4 |
CBA
4
Coastal Bridge Advisors
Westport,
Connecticut
|
$14.9K |
5 |
5
BlackRock
New York
|
$459K |